Work

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial.

Year: 1995

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1995.13.1.79

Authors: D F Bajorin, C R Nichols, H J Schmoll, P W Kantoff, C Bokemeyer, G D Demetri, L H Einhorn, G J Bosl

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1904771832

FWCI: 1.831

Cites: 16

Cited by: 38

Related to: 10